Prothena (PRTA) has released an update.
Prothena Corporation plc has expanded its Board of Directors and appointed Daniel G. Welch as a director and the upcoming Chair of the Board, effective immediately. Welch’s new role comes with an option to acquire 132,000 company shares, vesting over five years, and additional compensation, including an annual cash retainer of $90,000. His appointment is based solely on merit, with no undisclosed arrangements influencing the decision, and includes standard indemnification agreements with the company.
For further insights into PRTA stock, check out TipRanks’ Stock Analysis page.
